Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
2320 Scientific Park Drive, Wilmington, NC, 28405, US
Alcami is a US contract development and manufacturing organization with 45+ years of experience advancing pharmaceuticals and biologics from development to delivery. Alcami provides fully integrated lab services, drug product manufacturing, and cGMP pharma storage and support services including calibration, validation and environmental monitoring.
Timothy Compton of Alcami shares insight on Alcami's role in ensuring a smooth transition from development to manufacturing.
Released By Alcami Corporation
Gain insights into the parenteral and fill-finish manufacturing markets, opportunities, and recent investments in the space.
25-year industry professional brings a track record of leading high-performing, client-centered business teams.
A $31 million investment will expand its sterile development and manufacturing operation in Charleston, SC.
Chad Bovero, James Fife, and Tobin Cowart promoted to senior leadership team.
Alcami to manufacture PharmaTher’s proprietary ketamine products for FDA Phase 3 clinical studies and global commercialization.
Alcami used a Gerteis Mini-Pactor® roller compactor to develop a capsule formulation and critical processing parameters at the target dosage in record time.
The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.
Sign up to get a close-up look at our US network of laboratories and hear about our expansion plans.
In this webinar, Alcami’s Brent Harlow will guide you through the necessity of these studies and how to successfully perform them for FDA approval.
Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process.
WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.
He succeeds Walter J. Kaczmarek III, who is stepping down as Chief Executive Officer.
Formulation and Method Development.
Parenteral Forms.
Wether you are a virtual start-up or a large organization, you and your patients deserve subject matter experts who take ownership of your program from clinical trals through commerical supply. Partnering with Alcami as your contract development and manufacturing organization connects you to a US-based team of dedicated professionals with over 40 years experience advancing […]
Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs)
Alcami, a leading United States-based contract development and manufacturing organization (CDMO), announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC. The investment will add a Gerteis Mini-Pactor® roller compactor and low humidity suites to Alcami’s existing 140,000 square foot campus in Wilmington, NC. The expansion, which is on track to be completed in the first […]
High-resolution mass spectrometry is a key component in the characterization of novel biologics and biosimilars.
Alternate methods of administering solid oral formulations are necessary to meet the needs of all patients.
by Chris Williams, Julia Spraul (pictured), and Alyssa McBurney
Provides the Morgpeth facility’s Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery.
By: Charlie Sternberg
Designed to further enable process optimization by maximizing cell growth, viability, and productivity for a wide range of applications.
Designed to increase titers and enhance bioprocessing performance of insulin-dependent CHO cell lines.
Enbumyst is the first and only intranasal loop diuretic approved in the U.S., offering a self-administered alternative between oral and intravenous diuretics.
By: Rachel Klemovitch
The trial tests PBGENE-HBV for patients with chronic Hepatitis B.
The acquisition adds Durect's lead asset, larsucosterol, to Bausch Health’s hepatology pipeline.
Medjamia is a physician and medical affairs leader with over 20 years of experience spanning biotechnology and medical devices.
Pacheco comes to Takeda from Eli Lilly where she oversaw complex portfolios in a range of leadership roles.
Positions Seattle site as a premier destination for mammalian and microbial biologic production in the Pacific Northwest life sciences hub.
Together, the companies will integrate IND Drafting and CMC Support into Wheeler's ModularCMC Platform.
Jones Healthcare Group on capacity, collaboration and what’s next in pharma packaging.
Released By Jones Healthcare Group
Potential treatment for Fragile X syndrome expected to enter Phase 2 trial in America and Europe.
PEPFAR will support the delivery of Lenacapavir for PrEP in high-incidence, resource-limited countries.
Rodebaugh will oversee process and analytical development as well as program management.
Exploring how innovation, collaboration, and technology are revolutionizing radiopharmaceutical delivery.
By: Tom Brennan
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
